Excerpt: Cathy Epley, President and CEO of Vesticon, a medical technology company with several products in development related to the diagnosis and treatment of vestibular disorders, stresses that such nuances are why it’s critical to be focused on an accurate diagnosis. “A definitive BPPV diagnosis will dictate the appropriate treatment according to which canal and which ear is affected.”

“Think of it as one of those games with the beads that you have to get into holes by moving the case,” Dr. Epley suggests. “You need to move the patient to move the particles out of the canal, but first you need to know where they are because there’s a finite way to move the patient to move debris out of that specific canal.”

Such diagnostic complexity is behind Vesticon’s cutting edge Epley Omniax™ - a multi-axial automated positioning device affectionately referred to as “the chair.” Currently in the final stages of testing for FDA clearance, the Omniax comes with proprietary software that provides eye diagnosis on three levels, monitors all ear canals in every position, provides guidance for moving the patient and offers printable reports for effective patient management.

“There’s a good chance you can guess right or simply move particles for short-term relief,” Ms. Epley notes, “but with the Epley Omniax^TM you can base your diagnosis on solid science rather than best guess, and thereby enhance the patient’s chance of quick and complete recovery.”